Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms

被引:147
作者
Bezzi, Marco [1 ]
Seitzer, Nina [1 ]
Ishikawa, Tomoki [1 ]
Reschke, Markus [1 ]
Chen, Ming [1 ]
Wang, Guocan [1 ]
Mitchell, Caitlin [1 ]
Ng, Christopher [1 ]
Katon, Jesse [1 ]
Lunardi, Andrea [1 ]
Signoretti, Sabina [2 ,3 ]
Clohessy, John G. [1 ,4 ]
Zhang, Jiangwen [5 ]
Pandolfi, Pier Paolo [1 ]
机构
[1] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Canc Res Inst,Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[4] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Preclin Murine Pharmacogenet Facil, Boston, MA USA
[5] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China
关键词
RESISTANT PROSTATE-CANCER; SUPPRESSOR-CELLS; CELLULAR SENESCENCE; MYELOID CELLS; DOUBLE-BLIND; MICROENVIRONMENT; METASTASIS; MACROPHAGES; NEUTROPHILS; MELANOMA;
D O I
10.1038/nm.4463
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multiple immune-cell types can infiltrate tumors and promote progression and metastasis through different mechanisms, including immunosuppression. How distinct genetic alterations in tumors affect the composition of the immune landscape is currently unclear. Here, we characterized the immune-cell composition of prostate cancers driven by the loss of the critical tumor suppressor gene Pten, either alone or in combination with the loss of Trp53, Zbtb7a or Pml. We observed a striking quantitative and qualitative heterogeneity that was directly dependent on the specific genetic events in the tumor and ranged from 'cold', noninflamed tumors to massively infiltrated landscapes-results with important therapeutic implications. Further, we showed these qualitative differences in transcriptomic analysis of human prostate cancer samples. These data suggest that patient stratification on the basis of integrated genotypic-immunophenotypic analyses may be necessary for successful clinical trials and tailored precision immunological therapies.
引用
收藏
页码:165 / +
页数:13
相关论文
共 63 条
[1]   A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis [J].
Acharyya, Swarnali ;
Oskarsson, Thordur ;
Vanharanta, Sakari ;
Malladi, Srinivas ;
Kim, Juliet ;
Morris, Patrick G. ;
Manova-Todorova, Katia ;
Leversha, Margaret ;
Hogg, Nancy ;
Seshan, Venkatraman E. ;
Norton, Larry ;
Brogi, Edi ;
Massague, Joan .
CELL, 2012, 150 (01) :165-178
[2]   Mhc class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma [J].
Atkins, D ;
Breuckmann, A ;
Schmahl, GE ;
Binner, P ;
Ferrone, S ;
Krummenauer, F ;
Strökel, S ;
Seliger, B .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (02) :265-273
[3]   Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma [J].
Bald, Tobias ;
Quast, Thomas ;
Landsberg, Jennifer ;
Rogava, Meri ;
Glodde, Nicole ;
Lopez-Ramos, Dorys ;
Kohlmeyer, Judith ;
Riesenberg, Stefanie ;
van den Boorn-Konijnenberg, Debby ;
Hoemig-Hoelzel, Cornelia ;
Reuten, Raphael ;
Schadow, Benjamin ;
Weighardt, Heike ;
Wenzel, Daniela ;
Helfrich, Iris ;
Schadendorf, Dirk ;
Bloch, Wilhelm ;
Bianchi, Marco E. ;
Lugassy, Claire ;
Barnhill, Raymond L. ;
Koch, Manuel ;
Fleischmann, Bernd K. ;
Foerster, Irmgard ;
Kastenmueller, Wolfgang ;
Kolanus, Waldemar ;
Hoelzel, Michael ;
Gaffal, Evelyn ;
Tueting, Thomas .
NATURE, 2014, 507 (7490) :109-+
[4]   Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene [J].
Borrello, MG ;
Alberti, L ;
Fischer, A ;
Degl'Innocenti, D ;
Ferrario, C ;
Gariboldi, M ;
Marchesi, F ;
Allavena, P ;
Greco, A ;
Collini, P ;
Pilotti, S ;
Cassinelli, G ;
Bressan, P ;
Fugazzola, L ;
Mantovani, A ;
Pierotti, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) :14825-14830
[5]   BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma [J].
Bradley, Sherille D. ;
Chen, Zeming ;
Melendez, Brenda ;
Talukder, Amjad ;
Khalili, Jahan S. ;
Rodriguez-Cruz, Tania ;
Liu, Shujuan ;
Whittington, Mayra ;
Deng, Wanleng ;
Li, Fenge ;
Bernatchez, Chantale ;
Radvanyi, Laszlo G. ;
Davies, Michael A. ;
Hwu, Patrick ;
Lizee, Gregory .
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (06) :602-609
[6]   Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards [J].
Bronte, Vincenzo ;
Brandau, Sven ;
Chen, Shu-Hsia ;
Colombo, Mario P. ;
Frey, Alan B. ;
Greten, Tim F. ;
Mandruzzato, Susanna ;
Murray, Peter J. ;
Ochoa, Augusto ;
Ostrand-Rosenberg, Suzanne ;
Rodriguez, Paulo C. ;
Sica, Antonio ;
Umansky, Viktor ;
Vonderheide, Robert H. ;
Gabrilovich, Dmitry I. .
NATURE COMMUNICATIONS, 2016, 7
[7]   Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth [J].
Bruchard, Melanie ;
Mignot, Gregoire ;
Derangere, Valentin ;
Chalmin, Fanny ;
Chevriaux, Angelique ;
Vegran, Frederique ;
Boireau, Wilfrid ;
Simon, Benoit ;
Ryffel, Bernhard ;
Connat, Jean Louis ;
Kanellopoulos, Jean ;
Martin, Francois ;
Rebe, Cedric ;
Apetoh, Lionel ;
Ghiringhelli, Francois .
NATURE MEDICINE, 2013, 19 (01) :57-64
[8]   The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data [J].
Cerami, Ethan ;
Gao, Jianjiong ;
Dogrusoz, Ugur ;
Gross, Benjamin E. ;
Sumer, Selcuk Onur ;
Aksoy, Buelent Arman ;
Jacobsen, Anders ;
Byrne, Caitlin J. ;
Heuer, Michael L. ;
Larsson, Erik ;
Antipin, Yevgeniy ;
Reva, Boris ;
Goldberg, Arthur P. ;
Sander, Chris ;
Schultz, Nikolaus .
CANCER DISCOVERY, 2012, 2 (05) :401-404
[9]   Elements of cancer immunity and the cancer-immune set point [J].
Chen, Daniel S. ;
Mellman, Ira .
NATURE, 2017, 541 (7637) :321-330
[10]  
Chen M., 2018, NAT GENET IN PRESS